AT319239B - Verfahren zur Herstellung von neuen heterocyclischen Verbindungen - Google Patents

Verfahren zur Herstellung von neuen heterocyclischen Verbindungen

Info

Publication number
AT319239B
AT319239B AT760671A AT760671A AT319239B AT 319239 B AT319239 B AT 319239B AT 760671 A AT760671 A AT 760671A AT 760671 A AT760671 A AT 760671A AT 319239 B AT319239 B AT 319239B
Authority
AT
Austria
Prior art keywords
preparation
heterocyclic compounds
new heterocyclic
new
compounds
Prior art date
Application number
AT760671A
Other languages
English (en)
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Application granted granted Critical
Publication of AT319239B publication Critical patent/AT319239B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AT760671A 1970-09-03 1971-09-01 Verfahren zur Herstellung von neuen heterocyclischen Verbindungen AT319239B (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB4209070 1970-09-03
GB3437671 1971-07-22
US32368473A 1973-01-15 1973-01-15
US524161A US3917614A (en) 1970-09-03 1974-11-15 1-Pyrrolyl alkylene-piperidines
US524028A US3912741A (en) 1970-09-03 1974-11-15 1-(Benzo{8 b{9 thienylalkyl)piperidines
US524027A US3907810A (en) 1970-09-03 1974-11-15 1-Imidazolylalkylene-piperidines
US524030A US3910932A (en) 1970-09-03 1974-11-15 1-Pyridylalkyl piperidines

Publications (1)

Publication Number Publication Date
AT319239B true AT319239B (de) 1974-12-10

Family

ID=27562647

Family Applications (2)

Application Number Title Priority Date Filing Date
AT297873A AT316553B (de) 1970-09-03 1971-09-01 Verfahren zur Herstellung von 1-substituierten Tetrahydropyridin- und Piperidinderivaten
AT760671A AT319239B (de) 1970-09-03 1971-09-01 Verfahren zur Herstellung von neuen heterocyclischen Verbindungen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT297873A AT316553B (de) 1970-09-03 1971-09-01 Verfahren zur Herstellung von 1-substituierten Tetrahydropyridin- und Piperidinderivaten

Country Status (11)

Country Link
US (4) US3917614A (de)
AT (2) AT316553B (de)
AU (1) AU461209B2 (de)
BE (1) BE772190A (de)
CA (1) CA955252A (de)
CH (3) CH598218A5 (de)
DE (1) DE2144080C2 (de)
FR (1) FR2105223B1 (de)
GB (1) GB1345872A (de)
NL (1) NL173954C (de)
SE (1) SE402284B (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4028365A (en) * 1970-09-03 1977-06-07 John Wyeth & Brother Limited Benz[g]indolyl compounds
US4046767A (en) * 1970-09-03 1977-09-06 John Wyeth & Brother Limited Piperidino compounds
JPS5760335B2 (de) * 1972-06-14 1982-12-18 Sumitomo Chemical Co
US4024147A (en) * 1972-06-30 1977-05-17 John Wyeth & Brother Limited Heterocyclic compounds
US4061758A (en) * 1972-06-30 1977-12-06 John Wyeth & Brother Limited Treating hypertension and central nervous system abnormalities
GB1459506A (en) * 1974-02-18 1976-12-22 Wyeth John & Brother Ltd Piperidine derivatives
GB1507462A (en) * 1974-03-21 1978-04-12 Gallardo Antonio Sa N-heterocyclic substituted benzamides methods for their preparation and compositions containing them
GB1593851A (en) * 1976-10-27 1981-07-22 Gallardo Antonio Sa N-(4-piperidyl)-benzamides and pharmaceutical compositions containing them
DE2513136C3 (de) * 1974-03-21 1981-04-30 Anphar S.A., Madrid N-(1-Benzylpiperid-4-yl)-benzamide, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate
US4069331A (en) * 1974-05-16 1978-01-17 Boehringer Ingelheim Gmbh N-(p-fluorobenzoyl-n-propyl)-4-piperidylamides and salts thereof
GB1498884A (en) * 1975-04-15 1978-01-25 Wyeth John & Brother Ltd Aminoacetamide-pyridyl-tetrahydropyridyl and-piperidyl derivatives
US4191683A (en) * 1975-05-28 1980-03-04 Ciba-Geigy Corporation Derivatives of 4-aminopiperidine as stabilizers for polymers
US4027028A (en) * 1975-11-10 1977-05-31 Science Union Et Cie Arylethers and pharmaceutical compositions
US4163789A (en) * 1976-02-17 1979-08-07 Anphar, S.A. Anti-psychotic (cycloalkenylalkylpiperidino) benzamides
GB1574418A (en) * 1976-11-16 1980-09-03 Anphar Sa Piperidine derivatives
GB1582239A (en) * 1976-12-11 1981-01-07 Wyeth John & Brother Ltd Piperidin-4-yl ureas and thioureas
US4962115A (en) * 1981-10-01 1990-10-09 Janssen Pharmaceutica N.V. Novel N-(3-hydroxy-4-piperidinyl)benzamide derivatives
FR2530632A1 (fr) * 1982-07-26 1984-01-27 Bouchara Emile Nouveaux derives substitues du 2,5-diamino 1,4-diazole, leurs procedes de preparation et les compositions pharmaceutiques en renfermant
JPS6084281A (ja) * 1983-09-14 1985-05-13 Yoshitomi Pharmaceut Ind Ltd 3−インド−ルカルボキサミド類
JPS60123485A (ja) * 1983-12-08 1985-07-02 Yoshitomi Pharmaceut Ind Ltd インド−ル−3−カルボキサミド誘導体
JPS60142981A (ja) * 1983-12-28 1985-07-29 Yoshitomi Pharmaceut Ind Ltd 3−インド−ルカルボキサミド誘導体
US4569933A (en) * 1984-04-13 1986-02-11 Cornu Pierre Jean Antihypertensive substituted derivatives of 2,5-diamino 1,4-diazole
ZA86171B (en) * 1985-01-16 1986-08-27 Hoffmann La Roche Polycyclic salts
JP2832979B2 (ja) * 1988-02-15 1998-12-09 武田薬品工業株式会社 不飽和カルボン酸アミド誘導体
US5280032A (en) * 1989-02-14 1994-01-18 Toyama Chemical Co., Ltd. 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same
US5210090A (en) * 1989-09-05 1993-05-11 G. D. Searle & Co. Substituted N-benzylpiperidine amides and cardiac regulatory compositions thereof
US5070094A (en) * 1989-09-05 1991-12-03 G. D. Searle & Co. N-benzyltropaneamides
US4992446A (en) * 1989-09-05 1991-02-12 G. D. Searle & Co. Tricyclic quinolizine amides
US5028616A (en) * 1989-09-05 1991-07-02 G. D. Searle & Co. N-benzylpiperidine amides
US5053413A (en) * 1989-09-05 1991-10-01 G. D. Searle & Co. N-benzylpiperidineisoindolinones
US5098915A (en) * 1989-09-05 1992-03-24 G. D. Searle & Co. Substituted N-benzylpiperidine amides
US5403847A (en) * 1992-11-13 1995-04-04 Synaptic Pharmaceutical Corporation Use of α1C specific compounds to treat benign prostatic hyperlasia
US6015819A (en) 1992-11-13 2000-01-18 Synaptic Pharmaceutical Corporation Use of alpha-1C specific compounds to treat benign prostatic hyperplasia
US5578611A (en) * 1992-11-13 1996-11-26 Synaptic Pharmaceutical Corporation Use of α-1C specific compounds to treat benign prostatic hyperplasia
CZ130595A3 (en) * 1992-11-20 1995-10-18 Kaken Pharma Co Ltd Acetamide derivatives, medicaments based thereon and aminoethanethiol derivatives
MXPA03000708A (es) 2000-07-26 2003-06-04 Smithkline Beecham Plc Aminopiperidin quinolinas y sus analogos azaisostericos con actividad antibacteriana.
FR2813306B1 (fr) * 2000-08-23 2005-10-21 Sanofi Synthelabo Aminoalkybenzoyl-benzofurannes ou benzothiophenes, leur procede de preparation et les compositions les contenant
GB0101577D0 (en) 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
US7312212B2 (en) 2002-01-29 2007-12-25 Glaxo Group Limited Aminopiperidine derivatives
EP1470131A2 (de) 2002-01-29 2004-10-27 Glaxo Group Limited "aminopiperidinverbindugen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen "
EP1485364B1 (de) 2002-03-13 2009-03-11 Janssen Pharmaceutica N.V. Aminocarbonylderivate als histone-deacetylase-inhibitoren
BR0307607A (pt) * 2002-03-13 2004-12-21 Janssen Pharmaceutica Nv Derivados de carbonilamino como inibidores de histona desacetilase
JP4725945B2 (ja) 2002-03-13 2011-07-13 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ヒストンデアセチラーゼの新規な阻害剤としてのスルホニルアミノ誘導体
KR20040093692A (ko) 2002-03-13 2004-11-08 얀센 파마슈티카 엔.브이. 히스톤 디아세틸라제의 신규한 저해제로서의 피페라지닐-,피페리디닐- 및 모르폴리닐-유도체
KR101261305B1 (ko) 2004-07-28 2013-05-08 얀센 파마슈티카 엔.브이. 히스톤 디아세틸라제의 신규한 저해제로의 치환된 인돌릴알킬 아미노 유도체
JP5055268B2 (ja) 2005-05-18 2012-10-24 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ヒストンデアセチラーゼの新規な阻害剤としての置換されたアミノプロペニルピペリジンまたはモルホリン誘導体
CN101370803B (zh) 2006-01-19 2012-12-12 詹森药业有限公司 作为组蛋白脱乙酰酶抑制剂的取代的吲哚基-烷基-氨基衍生物
CA2630717C (en) 2006-01-19 2015-02-24 Janssen Pharmaceutica N.V. Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
DE602007001190D1 (de) 2006-01-19 2009-07-09 Janssen Pharmaceutica Nv Aminophenylderivate als neue inhibitoren von histondeacetylase
AU2007206944B2 (en) 2006-01-19 2012-08-23 Janssen Pharmaceutica N.V. Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL267843A (de) * 1960-08-03
US3270026A (en) * 1963-07-03 1966-08-30 Hoffmann La Roche Substituted benzamidotetrahydro-pyridines and processes
GB1154744A (en) * 1966-05-17 1969-06-11 Whitefin Holding Sa Disubstituted Aminoethanols
GB1221061A (en) * 1967-01-18 1971-02-03 May & Baker Ltd Quaternary ammonium derivatives, their use as anthelmintics and methods for their preparation
US3855242A (en) * 1967-12-15 1974-12-17 Aspro Nicholas Ltd Benzo{8 b{9 thienyl-alkyl-guanidines
DE2060816C3 (de) * 1970-12-10 1980-09-04 Merck Patent Gmbh, 6100 Darmstadt 4-Phenylpiperidinderivate Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen enthaltend diese Verbindungen

Also Published As

Publication number Publication date
US3907810A (en) 1975-09-23
NL173954B (nl) 1983-11-01
AU3300571A (en) 1973-03-08
CH593258A5 (de) 1977-11-30
US3910932A (en) 1975-10-07
CH598218A5 (de) 1978-04-28
SE402284B (sv) 1978-06-26
US3917614A (en) 1975-11-04
CA955252A (en) 1974-09-24
US3912741A (en) 1975-10-14
FR2105223A1 (de) 1972-04-28
DE2144080C2 (de) 1983-12-08
FR2105223B1 (de) 1975-10-10
BE772190A (fr) 1972-01-17
AU461209B2 (en) 1975-05-22
CH598219A5 (de) 1978-04-28
NL7112176A (de) 1972-03-07
NL173954C (nl) 1984-04-02
DE2144080A1 (de) 1972-03-09
AT316553B (de) 1974-07-25
GB1345872A (en) 1974-02-06

Similar Documents

Publication Publication Date Title
AT319239B (de) Verfahren zur Herstellung von neuen heterocyclischen Verbindungen
AT313268B (de) Verfahren zur Herstellung von neuen 5-Aroylpyrrolderivaten
AT296331B (de) Verfahren zur Herstellung von neuen N-heterocyclischen Verbindungen
AT317163B (de) Verfahren zur Herstellung von neuen polyhydroxylierten Verbindungen
AT304530B (de) Verfahren zur Herstellung von neuen substituierten Phenyl-2-pyrrolidinonen
AT314729B (de) Verfahren zur Herstellung von neuen 3-Hydroxy-3-methylcephamverbindungen
AT318812B (de) Verfahren zur Herstellung von neuen Cephalosporinverbindungen
AT304541B (de) Verfahren zur Herstellung von neuen Thiazolidinderivaten
AT315361B (de) Verfahren zur Herstellung von neuen Cephalosporinverbindungen
AT302288B (de) Verfahren zur Herstellung von neuen heterocyclischen Verbindungen
AT315362B (de) Verfahren zur Herstellung von neuen Cephalosporinverbindungen
AT317447B (de) Verfahren zur Herstellung von neuen heterocyclischen Verbindungen
AT310354B (de) Verfahren zur Herstellung von neuen Cephalosporinverbindungen
AT311334B (de) Verfahren zur Herstellung von neuen heterocylischen Verbindungen
CH533097A (de) Verfahren zur Herstellung von neuen heterocyclischen Verbindungen
AT313901B (de) Verfahren zur Herstellung von neuen Tetrahydropyrimidinverbindungen
AT308731B (de) Verfahren zur Herstellung von neuen 1-Aminoalkyl-benzcycloalkan-2-spirocycloaliphatischen Verbindungen
AT312171B (de) Verfahren zur Herstellung von neuen Imidazolribosylcyclophosphaten
AT308103B (de) Verfahren zur Herstellung von neuen Tetrazol-Anthrachinonverbindungen
CH541568A (de) Verfahren zur Herstellung von neuen Imidazolidinonderivaten
AT310761B (de) Verfahren zur Herstellung von neuen Triazolobenzodiazepin-5N-oxyd-Derivaten
AT305301B (de) Verfahren zur Herstellung von neuen 6-Chlorpyridaziniumverbindungen
AT303726B (de) Verfahren zur Herstellung von neuen Triazol-pyrimidinderivaten
AT308730B (de) Verfahren zur Herstellung von neuen 1-Aminoalkyl-benzcycloalkan-2-spirocycloaliphatischen Verbindungen
AT320143B (de) Verfahren zur Herstellung von neuen Cephalosporinverbindungen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee